TFX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Teleflex Inc (TFX) does not present a compelling buy opportunity at this moment for a beginner investor with a long-term focus. Despite some positive catalysts such as a planned $1 billion share buyback and debt reduction, the company's recent financial performance, negative shareholder returns, and lack of strong trading signals suggest a cautious approach. The technical indicators and options data do not indicate a strong upward momentum, and hedge funds are actively selling the stock. Holding or exploring alternative investments may be a better strategy.
The MACD is positively expanding with a histogram of 1.173, indicating a potential upward momentum. However, the RSI is neutral at 69.07, and the moving averages are converging, showing no clear trend. The stock is trading near its resistance level of R1 (118.652), with support at S1 (105.32). Overall, the technical indicators suggest a mixed outlook with no strong buy signal.
Planned $1 billion share buyback and $800 million debt reduction.
Analysts highlight potential earnings growth and mid-single-digit organic growth by
Recent upgrades from Raymond James and Needham with price targets of $128 and $138, respectively.
Hedge funds are actively selling the stock, with a 143.92% increase in selling activity over the last quarter.
Irenic Capital highlights a negative 73% shareholder return over five years and calls for board changes.
Q4 financials show a significant net income loss of -$714.33 million and a drop in gross margin to 56.24%.
In Q4 2025, revenue remained flat with no YoY growth. Net income increased significantly to -$714.33 million (up 422.72% YoY), but this is still a substantial loss. EPS improved to -16.15 (up 447.46% YoY), and gross margin dropped to 56.24% (down -7.86% YoY). Overall, the financial performance is weak, with no clear growth trends.
Recent analyst ratings are mixed but leaning positive. Raymond James upgraded the stock to Outperform with a $128 price target, citing improved investability and earnings power by 2027. Needham upgraded the stock to Buy with a $138 price target, highlighting significant earnings accretion from share repurchases. However, Wells Fargo lowered its price target to $116, citing cautious guidance.
